Navigation Links
CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
Date:1/17/2012

SEATTLE, Jan. 17, 2012 /PRNewswire/ -- CompleGen, Inc. announced today that they have executed a non-exclusive services agreement regarding CompleGen's XenoGene™ technology.  Boehringer Ingelheim's discovery team will apply the technology to explore targets that are not easily accessible by other discovery platforms.

CompleGen's XenoGene™ technology uses the power of genetics to identify allosteric inhibitors that are selective for specific protein targets.

"We are very pleased to be working with Boehringer Ingelheim to open pathways for therapeutics that have proved to be elusive previously," commented Pauline Gee, CompleGen's VP Business Development.

About CompleGen

CompleGen is a drug discovery company that uses its proprietary discovery platform, XenoGene™ technology to identify and develop selective inhibitors for difficult targets.  With its small molecule library, CompleGen has identified potent allosteric inhibitors for targets where other discovery platforms have failed.  These allosteric inhibitors have been shown to be efficacious and well tolerated in animals.  www.complegen.com

Contact:
Pauline Gee, PhD
Vice President, Business Development
CompleGen, Inc.
1124 Columbia Street, Suite 662
Seattle, WA 98104
pgee@complegen.com
+1.303.961.1773


'/>"/>
SOURCE CompleGen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Incisive Surgical Announces Breakthrough Peer Review Clinical Study
2. Molnlycke Health Care U.S. Announces Senior Management Change
3. Zimmer Announces Acquisition of Synvasive Technology, Inc.
4. MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit
5. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
6. Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology
7. Practice Fusion Announces New Funding to Support EMR Growth in 2012
8. LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool
9. BNA Books Announces the Publication of the 2011 Cumulative Supplement to "Pharmaceutical Law: Regulation of Research, Development, and Marketing"
10. NewCardio Announces Changes in Board of Directors and Executive Management
11. RSB Spine, LLC, Announces United States Patent Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):